Hepatitis C virus antibody seropositivity is associated with albuminuria but not peripheral artery disease in patients with type 2 diabetes
“In conclusion, severely increased albuminuria, but not the ABI, showed a significant association with HCV Ab seropositivity in patients aged ≥ 50 years with type 2 DM.”
Providers May Be Overlooking Average-Risk Patients for HCV Screening
“Although the US Preventive Services Task Force recommends universal hepatitis C virus (HCV) screening for all individuals 18-79 years of age, findings from a recent study suggest providers may still be basing their recommendations on patient risk factors and overlooking screening in patients perceived to be at average-risk of infection.”
NAFLD, Viral Hepatitis Among Liver Diseases Associated With Risk of Incident Cataract
“Liver diseases and their comorbid conditions extend well beyond the liver – extrahepatic manifestations often present as a result of the metabolic alterations and immune-mediated inflammation associated with liver disease, although findings from a recent study are providing novel insight into the association between hepatic and ophthalmic diseases.”
Eliminating Hepatitis C
“What we understand about viruses has changed immensely over my 35 years as a nurse. I was taught that we couldn’t cure viruses because they change too rapidly—think of the flu—and the best we could do was immunize against some of them. During the course of my career, we have done so much better than that, and this gives me hope and excitement for the future.”
Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO study
“Self-reported adherence to direct-acting antivirals (DAAs) to treat hepatitis C virus (HCV) among persons who inject drugs (PWID) is often an overreport of objectively measured adherence. The association of such overreporting with sustained virologic response (SVR) is understudied. This study among PWID aimed to determine a threshold of overreporting adherence that optimally predicts lower SVR rates, and to explore correlates of the optimal overreporting threshold.”
Lung Transplant With HCV-Viremic Organ Does Not Increase Rejection, Allograft Dysfunction
“Findings from a recent single-center study are highlighting the feasibility and success of using hepatitis C virus (HCV)-positive donor organs for lung transplantation, showing no increase in acute or chronic lung allograft rejection compared to HCV-negative donor organs.”
